Don’t forget all the damage that has been done by using reusable needles in developing nations……. What an idea that has been, trying to avoid disease by spreading it. - SM

http://www.chemind.org/news/issue14/story1.html

PowderJect points to vaccines

As part of its transformation into a vaccine company, PowderJect is planning to sell off the needle-free injection technology that led to the company's creation.
The UK firm was set up to develop a syringe that delivers drugs through the skin using a burst of helium, removing the pain and injury associated with needles. However, this promising technology has yet to deliver.
In a move welcomed by investors, the company is positioning itself firmly as a vaccine company. Selling its powder injection rights will allow it to focus on strengthening its position as the world's number six vaccine company, an aim bolsterd by its recent acquisition of Sweden's leading vaccine company SBL Vaccin.
With estimates that the vaccine market will grow from its current value of $6.5bn to $20bn in ten years time, the transition is sensible, say observers.
With the purchase of SBL Vaccin, and Evans and Medeva vaccines in 2000, as well as successful trials for the pain killer lidocaine in powder injection form, PowderJect now has nine approved products, three vaccines in phase III and a pipeline of over ten vaccines
SkyePharma has been suggested as a possible buyer of the needleless technology. PowderJect is not selling the rights for the technology concerned with the delivery of DNA based vaccines.

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.